T. A. Moreland

1.3k total citations
35 papers, 943 citations indexed

About

T. A. Moreland is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, T. A. Moreland has authored 35 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 7 papers in Pharmacology and 6 papers in Psychiatry and Mental health. Recurrent topics in T. A. Moreland's work include Pharmacological Effects and Toxicity Studies (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Pharmaceutical studies and practices (7 papers). T. A. Moreland is often cited by papers focused on Pharmacological Effects and Toxicity Studies (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Pharmaceutical studies and practices (7 papers). T. A. Moreland collaborates with scholars based in United Kingdom, United States and France. T. A. Moreland's co-authors include D S Hewick, René H. Levy, Ian H. Stevenson, Alexander M. M. Shepherd, G Rylance, John McEwen, Christian de Mey, Martin C. Michel, P Loiseau and Henri Bléhaut and has published in prestigious journals such as Clinical Infectious Diseases, European Heart Journal and British Journal of Pharmacology.

In The Last Decade

T. A. Moreland

35 papers receiving 860 citations

Peers

T. A. Moreland
P. K. M. Lunde Norway
Charles E. Halstenson United States
C. H. Kleinbloesem Switzerland
R. Dahlqvist Sweden
J. Mølholm Hansen Denmark
Ingegerd Odar‐Cederlöf Sweden
E. Weber Germany
Yukinao Kohda Japan
J. P. Kampmann Denmark
Mark J. Goldberg United States
P. K. M. Lunde Norway
T. A. Moreland
Citations per year, relative to T. A. Moreland T. A. Moreland (= 1×) peers P. K. M. Lunde

Countries citing papers authored by T. A. Moreland

Since Specialization
Citations

This map shows the geographic impact of T. A. Moreland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. A. Moreland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. A. Moreland more than expected).

Fields of papers citing papers by T. A. Moreland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. A. Moreland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. A. Moreland. The network helps show where T. A. Moreland may publish in the future.

Co-authorship network of co-authors of T. A. Moreland

This figure shows the co-authorship network connecting the top 25 collaborators of T. A. Moreland. A scholar is included among the top collaborators of T. A. Moreland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. A. Moreland. T. A. Moreland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mey, Christian de, Martin C. Michel, John McEwen, & T. A. Moreland. (1998). A Double-Blind Comparison of Terazosin and Tamsulosin on Their Differential Effects on Ambulatory Blood Pressure and Nocturnal Orthostatic Stress Testing. European Urology. 33(5). 481–488. 80 indexed citations
3.
Lang, Chim C., T. A. Moreland, Anna Maria Choy, et al.. (1995). Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance. European Journal of Clinical Pharmacology. 48(6). 429–34. 4 indexed citations
4.
Wilcox, M. H., et al.. (1991). Relationship between cefpirome clearance, serum creatinine, weight and age in patients treated for infection. Journal of Antimicrobial Chemotherapy. 28(2). 291–299. 3 indexed citations
5.
Lang, Chim C., T. A. Moreland, & Peter Davey. (1990). Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods. Journal of Antimicrobial Chemotherapy. 25(4). 645–650. 17 indexed citations
6.
Moreland, T. A., et al.. (1989). Multiple dose comparison of a whole 240 mg verapamil sustained‐release tablet with two half tablets. Biopharmaceutics & Drug Disposition. 10(3). 311–319. 5 indexed citations
7.
McEwen, John, et al.. (1989). Sustained-release verapamil: multiple-dose pharmacokinetic comparison of 120-mg and 240-mg tablets and the effect of halving a 240-mg tablet.. PubMed. 13 Suppl 4. S57–9. 8 indexed citations
8.
Lipworth, Brian J., Robert A. Clark, D.P. Dhillon, et al.. (1989). Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in Patients with asthma. European Journal of Clinical Pharmacology. 37(6). 567–571. 34 indexed citations
9.
McEwen, J., et al.. (1989). Sustained-Release Verapamil. Journal of Cardiovascular Pharmacology. 13. S57–S59. 7 indexed citations
10.
Moreland, T. A., et al.. (1988). A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation. European Heart Journal. 9(3). 279–283. 39 indexed citations
11.
12.
McEwen, John, et al.. (1988). The effects of once-daily dosing with ranitidine and cimetidine on theophylline pharmacokinetics. European Journal of Drug Metabolism and Pharmacokinetics. 13(3). 201–205. 6 indexed citations
13.
Moreland, T. A., et al.. (1986). The metabolic fate of stiripentol in man.. Drug Metabolism and Disposition. 14(6). 654–662. 36 indexed citations
14.
Rylance, G & T. A. Moreland. (1979). DRUG USE IN THE NEWBORN. Journal of Clinical Pharmacy and Therapeutics. 4(2). 95–100. 1 indexed citations
15.
Moreland, T. A., et al.. (1979). Effects of pethidine and its antagonists on the newborn.. Archives of Disease in Childhood. 54(5). 356–361. 17 indexed citations
16.
Moreland, T. A., et al.. (1978). Patterns of drug prescribing for children in hospital. European Journal of Clinical Pharmacology. 14(1). 39–46. 25 indexed citations
17.
Shepherd, Alexander M. M., D S Hewick, T. A. Moreland, & Ian H. Stevenson. (1977). Age as a determinant of sensitivity to warfarin.. British Journal of Clinical Pharmacology. 4(3). 315–320. 190 indexed citations
18.
Hewick, D S & T. A. Moreland. (1975). Proceedings: An NADPH dependent warfarin reductase in human and rat liver and kidney soluble fraction.. British Journal of Pharmacology. 53(3). 441. 1 indexed citations
19.
Hewick, D S, T. A. Moreland, Alexander M. M. Shepherd, & Ian H. Stevenson. (1975). The effect of age on the sensitivity to warfarin sodium. British Journal of Clinical Pharmacology. 2(2). 16 indexed citations
20.
Moreland, T. A. & D S Hewick. (1975). Studies on a ketone reductase in human and rat liver and kidney soluble fraction using warfarin as a substrate. Biochemical Pharmacology. 24(21). 1953–1957. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. K. M. Lunde Breakdown of academic impact, for papers by Charles E. Halstenson Breakdown of academic impact, for papers by C. H. Kleinbloesem Breakdown of academic impact, for papers by R. Dahlqvist Breakdown of academic impact, for papers by J. Mølholm Hansen Breakdown of academic impact, for papers by Ingegerd Odar‐Cederlöf Breakdown of academic impact, for papers by E. Weber Breakdown of academic impact, for papers by Yukinao Kohda Breakdown of academic impact, for papers by J. P. Kampmann Breakdown of academic impact, for papers by Mark J. Goldberg
Rankless by CCL
2026